Jbtor 100 Tablet contains Torasemide 100mg, a potent loop diuretic used primarily in the management of edema associated with congestive heart failure, renal impairment, and hepatic cirrhosis. Torasemide acts on the thick ascending limb of the loop of Henle in the nephron, inhibiting the sodium-potassium-chloride co-transporter, which results in increased excretion of sodium, chloride, and water. This mechanism effectively reduces fluid overload and decreases blood pressure, making Jbtor 100 Tablet beneficial in treating hypertension resistant to other diuretics. The drug’s pharmacokinetic profile allows for once-daily dosing, enhancing patient compliance. Jbtor 100 Tablet should be administered under medical supervision, with careful monitoring of electrolyte levels, renal function, and blood pressure to avoid potential adverse effects such as hypokalemia, dehydration, or renal impairment. Contraindications include anuria, severe electrolyte imbalance, and hypersensitivity to Torasemide or sulfonamides. Caution is advised in patients with diabetes mellitus, gout, or those on concomitant antihypertensive therapy. Jbtor 100 Tablet is a valuable therapeutic option in managing fluid retention and hypertension, contributing to improved cardiovascular and renal outcomes when used appropriately as part of a comprehensive treatment plan.